149 related articles for article (PubMed ID: 430180)
1. Absorbed dose to the human adrenals from lodomethylnorcholesterol (I-131) "NP-59": concise communication.
Carey JE; Thrall JH; Freitas JE; Beierwaltes WH
J Nucl Med; 1979 Jan; 20(1):60-2. PubMed ID: 430180
[TBL] [Abstract][Full Text] [Related]
2. [Measurement of percent uptake in the adrenal glands with 131I-adosterol (author's transl)].
Fujita T; Fukunaga M; Mukai T; Yamamoto I; TorizukaD okoh S; Ishii Y; Morita R; Kawamura K; Kawamura J
Kaku Igaku; 1980 Mar; 17(2):219-27. PubMed ID: 7382187
[No Abstract] [Full Text] [Related]
3. The relationship of serum lipids to adrenal-gland uptake of 6 beta-[131I]iodomethyl-19-norcholesterol in Cushing's syndrome.
Valk TW; Gross MD; Freitas JE; Swanson DP; Schteingart DE; Beierwaltes WH
J Nucl Med; 1980 Nov; 21(11):1069-72. PubMed ID: 7431105
[TBL] [Abstract][Full Text] [Related]
4. Failure to visualize adrenal glands in a patient with bilateral adrenal hyperplasia.
Gordon L; Mayfield RK; Levine JH; Lopes-Virella MF; Sagel J; Buse MG
J Nucl Med; 1980 Jan; 21(1):49-51. PubMed ID: 7356739
[TBL] [Abstract][Full Text] [Related]
5. Adrenal scintiscanning with NP-59, a new radioiodinated cholesterol agent.
Miles JM; Wahner HW; Carpenter PC; Salassa RM; Northcutt RC
Mayo Clin Proc; 1979 May; 54(5):321-7. PubMed ID: 431134
[TBL] [Abstract][Full Text] [Related]
6. The relationship of adrenal iodomethylnorcholesterol uptake to indices of adrenal cortical function in Cushing's syndrome.
Gross MD; Valk TW; Freitas JE; Swanson DP; Schteingart DE; Beierwaltes WH
J Clin Endocrinol Metab; 1981 Jun; 52(6):1062-6. PubMed ID: 6262361
[TBL] [Abstract][Full Text] [Related]
7. Adrenal scanning and uptake with 131I-6beta-iodomethyl-nor-cholesterol.
Ryo UY; Johnston AS; Kim I; Pinsky SM
Radiology; 1978 Jul; 128(1):157-61. PubMed ID: 663202
[TBL] [Abstract][Full Text] [Related]
8. The diagnosis of Cushing's syndrome using 131I-19-iodocholesterol uptake and adrenal imaging.
Ortega D; Foz M; Doménech-Torné FM; Tresánchez JM
Clin Endocrinol (Oxf); 1980 Aug; 13(2):145-9. PubMed ID: 7438469
[TBL] [Abstract][Full Text] [Related]
9. [Scintigraphy of the adrenals using 131I-bimetrol].
Starovoĭtova LP; Sedov VV; Vorob'eva EN; Kozyreva-Aleksandrova LS; Levin VI
Med Radiol (Mosk); 1982 Nov; 27(11):66-70. PubMed ID: 7176865
[No Abstract] [Full Text] [Related]
10. Atlas of iodocholesterol scintigraphy (NP-59) in Cushing's syndrome with CT and MR correlation.
Yu KC; Fraker DL; Ziessman HA
Clin Nucl Med; 1996 Feb; 21(2):136-41. PubMed ID: 8697685
[TBL] [Abstract][Full Text] [Related]
11. Radiation dosimetry of adrenal imaging agents 19-iodocholesterol and 6-iodomethylnorcholesterol.
Brookeman VA
Int J Appl Radiat Isot; 1978 May; 29(4-5):277-9. PubMed ID: 689751
[No Abstract] [Full Text] [Related]
12. [Clinical values of adrenal scintigraphy by I-6-beta-iodomethyl-19-norcholesterol (123I-NCL) (author's transl)].
Tateno Y; Shishido F; Kamoi I; Matsuura K; Takagi Y; Hashimoto S; Hotta T; Arimizu N; Fukushi K; Irie T; Ido T; Kojima M; Maeda M; Ogawa H; Itoh T
Kaku Igaku; 1982 Mar; 19(2):245-53. PubMed ID: 7109324
[No Abstract] [Full Text] [Related]
13. [Adrenal scintigraphy using 131I-adosterol--as to the usefulness of dexamethasone suppression scintigraphy (author's transl)].
Fukunaga M; Dokoh S; Yamamoto I; Morita R; Torizuka K; Fujita T; Kono T; Tanimura H; Shinpo S
Radioisotopes; 1977 Dec; 26(12):864-8. PubMed ID: 605223
[No Abstract] [Full Text] [Related]
14. Imaging the adrenal glands with radiolabeled inhibitors of enzymes: concise communication.
Beierwaltes WH; Wieland DM; Mosley ST; Swanson DP; Sarkar SD; Freitas JE; Thrall JH; Herwig KR
J Nucl Med; 1978 Feb; 19(2):200-3. PubMed ID: 627901
[TBL] [Abstract][Full Text] [Related]
15. The normal dexamethasone-suppression adrenal scintiscan.
Gross MD; Freitas JE; Swanson DP; Brady T; Beierwaltes WH
J Nucl Med; 1979 Nov; 20(11):1131-5. PubMed ID: 536772
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of adrenal imaging with 123I-labeled-6 beta-iodomethyl-19-norcholesterol (author's transl)].
Shishido F; Tateno Y; Ido T; Irie T; Suzuki K; Fukushi K; Iwata R; Kojima M; Maeda M; Ito T; Ogawa H
Radioisotopes; 1980 Nov; 29(11):526-32. PubMed ID: 7244299
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of a new adrenal scanning agent, 6-methyl-75Se-selenomethyl-19-norcholest-5 (10)-en-3 beta-ol (75Se-Scintadren) and 6 beta-iodomethyl-19-norcholest-5 (10)-en-3 beta-ol (131I-Adosterol) (author's transl)].
Seto H; Futatsuya R; Mori H; Koizumi K; Hisada K
Kaku Igaku; 1979 Apr; 16(2):183-9. PubMed ID: 470240
[No Abstract] [Full Text] [Related]
18. Diagnostic accuracy and pitfalls of [iodine-131]6-beta-iodomethyl-19-norcholesterol (NP-59) imaging.
Kazerooni EA; Sisson JC; Shapiro B; Gross MD; Driedger A; Hurwitz GA; Mattar AG; Petry NA
J Nucl Med; 1990 Apr; 31(4):526-34. PubMed ID: 2324830
[TBL] [Abstract][Full Text] [Related]
19. A new adrenal computer imaging technique using dual-radioisotopes.
Ohashi T; Morioka M; Mitsuhata N; Akaeda T; Ohmori H
Acta Med Okayama; 1981 Jun; 35(3):165-72. PubMed ID: 6457507
[TBL] [Abstract][Full Text] [Related]
20. Selenium 75 selenomethyl cholesterol: a new agent for quantitative functional scintigraphy of the adrenals: physical aspects.
Hawkins LA; Britton KE; Shapiro B
Br J Radiol; 1980 Sep; 53(633):883-9. PubMed ID: 7437711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
